[Biologics in Rhinology - Forthcoming Personalized Concepts: the Future Starts Today]. (Q64905539)

30 June 2019

2 references

14 November 2020

18 November 2020

[Biologics in Rhinology - Forthcoming Personalized Concepts: the Future Starts Today]. (English)

1 reference

30 June 2019

2 references

14 November 2020

18 November 2020

1 reference

14 November 2020

1 reference

18 November 2020

Adam M Chaker

1 reference

30 June 2019

language of work or name

German

0 references

publication date

22 March 2018

1 reference

30 June 2019

1 March 2018

2 references

14 November 2020

18 November 2020

Laryngo- rhino- otologie

3 references

30 June 2019

14 November 2020

18 November 2020

1 reference

30 June 2019

issue

S 01

1 reference

30 June 2019

page(s)

S142-S184

1 reference

30 June 2019

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

2 references

14 November 2020

The ethmoidal infundibulum and its inflammatory illnesses (author's transl)

18 November 2020

cites work

1 reference

12 December 2020

Nasal polyps in asthma and rhinitis. A review of 6,037 patients

1 reference

12 December 2020

The presence of IgE on the surface of lymphocytes in nasal polyps*1

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Characterization and Quantification of Cellular Infiltrates in Nasal Mucosa of Patients with Grass Pollen Allergy, Non-Allergic Patients with Nasal Polyps and Controls

1 reference

12 December 2020

Langerhans Cells in Nasal Mucosa of Patients with Grass Pollen Allergy

1 reference

12 December 2020

Functional endoscopic sinus surgery. Concept, indications and results of the Messerklinger technique

1 reference

12 December 2020

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

1 reference

12 December 2020

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

12 December 2020

Risk factors for asthma up to 16 years of age. Evidence from a national cohort study

1 reference

12 December 2020

Allergen-binding activity of gamma-E, gamma-G and gamma-A antibodies in sera from atopic patients. In vitro measurements of reaginic antibody.

1 reference

12 December 2020

Raised levels of a new immunoglobulin class (IgND) in asthma

1 reference

12 December 2020

Immunological studies of an atypical (myeloma) immunoglobulin.

1 reference

12 December 2020

IgE in allergic diseases

1 reference

12 December 2020

Immunoglobulins in nasal polyp fluid.

1 reference

12 December 2020

Mucosal and glandular distribution of immunoglobulin components: differential localization of free and bound SC in secretory epithelial cells

1 reference

12 December 2020

IgA subclasses in various secretions and in serum

1 reference

12 December 2020

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA

1 reference

12 December 2020

Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol.

1 reference

12 December 2020

Phenotypic and molecular characteristics of nasal mucosal gamma delta T cells in allergic and infectious rhinitis

1 reference

12 December 2020

Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection?

1 reference

12 December 2020

IL-5 synthesis is upregulated in human nasal polyp tissue1

1 reference

12 December 2020

The not-so-good old days: Working with pituitary growth hormone in North America, 1956 to 1985

1 reference

12 December 2020

IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis

1 reference

12 December 2020

Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1.

1 reference

12 December 2020

Prion diseases and blood transfusion

1 reference

12 December 2020

Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.

1 reference

12 December 2020

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions

1 reference

12 December 2020

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

1 reference

12 December 2020

Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients

1 reference

12 December 2020

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

12 December 2020

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

1 reference

12 December 2020

Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways

1 reference

12 December 2020

Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season

1 reference

12 December 2020

Total and specific IgE in nasal polyps is related to local eosinophilic inflammation

1 reference

12 December 2020

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

12 December 2020

Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa

1 reference

12 December 2020

Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin

1 reference

12 December 2020

The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air

1 reference

12 December 2020

Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.

1 reference

12 December 2020

Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis.

1 reference

12 December 2020

First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely?

1 reference

12 December 2020

The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study

1 reference

12 December 2020

The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis

1 reference

12 December 2020

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

1 reference

12 December 2020

Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes

1 reference

12 December 2020

Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis

1 reference

12 December 2020

Humanization of Predicted T-Cell Epitopes Reduces the Immunogenicity of Chimeric Antibodies: New Evidence Supporting a Simple Method

1 reference

12 December 2020

Atopic dermatitis and the atopic march

1 reference

12 December 2020

Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis

1 reference

12 December 2020

Let's go mucosal: communication on slippery ground

1 reference

12 December 2020

Cilia-related diseases

1 reference

12 December 2020

Tregs and allergic disease

1 reference

12 December 2020

Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue.

1 reference

12 December 2020

Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators

1 reference

12 December 2020

Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.

1 reference

12 December 2020

Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

1 reference

12 December 2020

An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis

1 reference

12 December 2020

The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy

1 reference

12 December 2020

Comparative analysis of nasal and oral mucosa dendritic cells

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

1 reference

12 December 2020

Wegener's granulomatosis--probing the untold past of the man behind the eponym

1 reference

12 December 2020

Differentiation of chronic sinus diseases by measurement of inflammatory mediators

1 reference

12 December 2020

Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps

1 reference

12 December 2020

Allergen injection immunotherapy for seasonal allergic rhinitis

1 reference

12 December 2020

Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age

1 reference

12 December 2020

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

12 December 2020

Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding

1 reference

12 December 2020

Severe cutaneous reaction during radiation therapy with concurrent cetuximab

1 reference

12 December 2020

High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history

1 reference

12 December 2020

Observations on the ability of the nose to warm and humidify inspired air.

1 reference

12 December 2020

The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study

1 reference

12 December 2020

Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy

1 reference

12 December 2020

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation

1 reference

12 December 2020

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

1 reference

12 December 2020

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

1 reference

12 December 2020

Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies

1 reference

12 December 2020

Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa

1 reference

12 December 2020

Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease

1 reference

12 December 2020

Rhinitis and onset of asthma: a longitudinal population-based study

1 reference

12 December 2020

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

1 reference

12 December 2020

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma

1 reference

12 December 2020

The immune geography of IgA induction and function

1 reference

12 December 2020

Phylogenetic Relationships and Molecular Adaptation Dynamics of Human Rhinoviruses

1 reference

12 December 2020

Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution

1 reference

12 December 2020

Mepolizumab and exacerbations of refractory eosinophilic asthma

1 reference

12 December 2020

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

1 reference

12 December 2020

Mechanisms and treatment of allergic disease in the big picture of regulatory T cells

1 reference

12 December 2020

Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously.

1 reference

12 December 2020

Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab

1 reference

12 December 2020

Biofilms in chronic rhinosinusitis: a review.

1 reference

12 December 2020

Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey

1 reference

12 December 2020

Unmet needs in severe chronic upper airway disease (SCUAD).

1 reference

12 December 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

12 December 2020

Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization

1 reference

12 December 2020

Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells

1 reference

12 December 2020

Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis

1 reference

12 December 2020

Efficacy of omalizumab in the treatment of nasal polyps.

1 reference

12 December 2020

Sublingual immunotherapy for allergic rhinitis

1 reference

12 December 2020

Quality of Life in Patients with Chronic Rhinosinusitis

1 reference

12 December 2020

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

1 reference

12 December 2020

Role of immunmodulators in allergen-specific immunotherapy

1 reference

12 December 2020

Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE.

1 reference

12 December 2020

Systematic reviews of sublingual immunotherapy (SLIT)

1 reference

12 December 2020

The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps

1 reference

12 December 2020

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study.

1 reference

12 December 2020

Expression of nitric oxide synthases in primary ciliary dyskinesia

1 reference

12 December 2020

Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?

1 reference

12 December 2020

Developing anti-TNF and biologic agents

1 reference

12 December 2020

Lebrikizumab Treatment in Adults with Asthma

1 reference

12 December 2020

Reslizumab for Poorly Controlled, Eosinophilic Asthma

1 reference

12 December 2020

Rheumatic disorders affecting the head and neck: underestimated diseases

1 reference

12 December 2020

A survey on the management of acute rhinosinusitis among Asian physicians.

1 reference

12 December 2020

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

1 reference

12 December 2020

Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis

1 reference

12 December 2020

Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy

1 reference

12 December 2020

History of growth hormone therapy

1 reference

12 December 2020

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe

1 reference

12 December 2020

IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis

1 reference

12 December 2020

Predictive capabilities of serum eosinophil cationic protein, percentage of eosinophils and total immunoglobulin E in allergic rhinitis without bronchial asthma

1 reference

12 December 2020

Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy

1 reference

12 December 2020

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

1 reference

12 December 2020

Nasal spray adherence after sinus surgery: problems and predictors

1 reference

12 December 2020

Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study

1 reference

12 December 2020

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

1 reference

12 December 2020

Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.

1 reference

12 December 2020

Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis

1 reference

12 December 2020

Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

1 reference

12 December 2020

Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies

1 reference

12 December 2020

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

1 reference

12 December 2020

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs

1 reference

12 December 2020

Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations

1 reference

12 December 2020

Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).

1 reference

12 December 2020

Biologics-induced autoimmune diseases

1 reference

12 December 2020

Evolution of treatment for rheumatoid arthritis

1 reference

12 December 2020

Clinical targeting of the TNF and TNFR superfamilies

1 reference

12 December 2020

Is the common cold a clinical entity or a cultural concept?

1 reference

12 December 2020

Rhinovirus wheezing illness and genetic risk of childhood-onset asthma

1 reference

12 December 2020

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

1 reference

12 December 2020

Dupilumab in persistent asthma with elevated eosinophil levels

1 reference

12 December 2020

[Prevalence of sensitisation to aeraoallergens and food allergens: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

1 reference

12 December 2020

[Prevalence of allergic diseases in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

1 reference

12 December 2020

Tick bites and red meat allergy

1 reference

12 December 2020

Inflammatory patterns in upper airway disease in the same geographical area may change over time

1 reference

12 December 2020

Complex phenotypes in asthma: current definitions

1 reference

12 December 2020

1 reference

12 December 2020

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

1 reference

12 December 2020

Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis

1 reference

12 December 2020

Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine

1 reference

12 December 2020

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

1 reference

12 December 2020

Staphylococcal enterotoxin sensitization in a community-based population: a potential role in adult-onset asthma.

1 reference

12 December 2020

Quantification of circulating house dust mite-specific IL-4- and IL-13-secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons

1 reference

12 December 2020

Systems medicine, stratified medicine, personalized medicine but not precision medicine

1 reference

12 December 2020

Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection

1 reference

12 December 2020

Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis

1 reference

12 December 2020

[Liposomal local therapy of sinunasal symptoms in ANCA associated vasculitis]

1 reference

12 December 2020

Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps

1 reference

12 December 2020

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

12 December 2020

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

1 reference

12 December 2020

Identifying the heterogeneity of young adult rhinitis through cluster analysis in the Isle of Wight birth cohort

1 reference

12 December 2020

Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps.

1 reference

12 December 2020

Galactose-alpha-1,3-galactose sensitization is a prerequisite for pork-kidney allergy and cofactor-related mammalian meat anaphylaxis

1 reference

12 December 2020

Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature

1 reference

12 December 2020

1 reference

12 December 2020

Surgical interventions for chronic rhinosinusitis with nasal polyps

1 reference

12 December 2020

Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps

1 reference

12 December 2020

Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions.

1 reference

12 December 2020

Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections

1 reference

12 December 2020

Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization

1 reference

12 December 2020

Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype.

1 reference

12 December 2020

1 reference

12 December 2020

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy

1 reference

12 December 2020

GINA, genetic discrimination, and genomic medicine

1 reference

12 December 2020

Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis

1 reference

12 December 2020

Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data

1 reference

12 December 2020

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

1 reference

12 December 2020

Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities and economic burden

1 reference

12 December 2020

Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options

1 reference

12 December 2020

Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2.

1 reference

12 December 2020

The burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study

1 reference

12 December 2020

The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses

1 reference

12 December 2020

[Individualized, personalized and stratified medicine: a challenge for allergology in ENT?]

1 reference

12 December 2020

Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study

1 reference

12 December 2020

Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme

1 reference

12 December 2020

A new era of personalized medicine for cystic fibrosis - at last!

1 reference

12 December 2020

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso

1 reference

12 December 2020

Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis

1 reference

12 December 2020

The Contribution of the Airway Epithelial Cell to Host Defense

1 reference

12 December 2020

Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa.

1 reference

12 December 2020

Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study

1 reference

12 December 2020

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors

1 reference

12 December 2020

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial

1 reference

12 December 2020

Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways.

1 reference

12 December 2020

Impact of medically recalcitrant chronic rhinosinusitis on incidence of asthma

1 reference

12 December 2020

Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis

1 reference

12 December 2020

Current and future biomarkers in allergic asthma

1 reference

12 December 2020

Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis

1 reference

12 December 2020

Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers

1 reference

12 December 2020

Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study

1 reference

12 December 2020

The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome

1 reference

12 December 2020

Topical steroids for nasal polyps

1 reference

12 December 2020

Different types of intranasal steroids for chronic rhinosinusitis

1 reference

12 December 2020

Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis

1 reference

12 December 2020

Lebrikizumab in the treatment of asthma

1 reference

12 December 2020

1 reference

12 December 2020

EAACI Molecular Allergology User's Guide

1 reference

12 December 2020

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

1 reference

12 December 2020

Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation.

1 reference

12 December 2020

Age dictates a steroid-resistant cascade of Wnt5a, transglutaminase 2, and leukotrienes in inflamed airways

1 reference

12 December 2020

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions

1 reference

12 December 2020

Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample

1 reference

12 December 2020

Omalizumab facilitates rapid oral desensitization for peanut allergy.

1 reference

12 December 2020

Chronic rhinosinusitis phenotypes

1 reference

12 December 2020

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

1 reference

12 December 2020

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

1 reference

12 December 2020

Wnt Signaling in Chronic Rhinosinusitis with Nasal Polyps

1 reference

12 December 2020

Interchangeability of Biosimilars: A European Perspective

1 reference

12 December 2020

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.

1 reference

12 December 2020

Endotypes in Chronic Rhinosinusitis: Biomarkers Based on a Mechanistic Insight for Targeted Treatment?

1 reference

12 December 2020

Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

1 reference

12 December 2020

Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology.

1 reference

12 December 2020

Biologics and biomarkers for asthma, urticaria, and nasal polyposis

1 reference

12 December 2020

The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps.

1 reference

12 December 2020

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

1 reference

12 December 2020

Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma

1 reference

12 December 2020

[Molecular component-resolved allergy diagnostics in ENT]

1 reference

12 December 2020

Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more

1 reference

12 December 2020

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

1 reference

12 December 2020

Endotype-driven treatment in chronic upper airway diseases.

1 reference

12 December 2020

Identifiers

DOI

10.1055/S-0043-123484

1 reference

30 June 2019

PMC publication ID

6541111

1 reference

30 June 2019

PubMed publication ID

29905356

1 reference

30 June 2019